Mastering Oligonucleotide Prep: Why Genevac Solvent Evaporation is Your Secret Weapon
14 June 2024
Oligonucleotides are revolutionising research and therapeutics, and their success hinges on meticulous sample preparation, whereby solvent evaporation can significantly impact downstream applications.
Biopharma Group, Genevac’s approved distribution partner for solvent evaporators, empowers you to unlock the full potential of your oligonucleotides with expert insights and the ideal technology.The Delicate Dance of Evaporation:
Efficient solvent removal concentrates oligonucleotides yet employing harsh techniques risk cross contamination and sample loss. Balancing speed, vacuum draw and temperature is paramount.
Genevac: Your Partner in Precision Evaporation for Oligos
Why? Solvent evaporators by Genevac are designed to offer unparalleled versatility whilst catering to the delicate nature of oligonucleotides.
- Controlled Concentration without Compromise: Unlike other methods prone to bumping and sample loss, Genevac's centrifugal evaporation with precise temperature control ensures gentle and efficient concentration. The innovative Dri-Pure technology actively prevents bumping during evaporation, eliminating sample loss and contamination as documented by GlaxoWelcome.
- Optimized for All Oligonucleotides: By understanding the diverse nature of oligonucleotides, Genevac systems provide more precise control over pressure, temperature, and rotation speed allows for optimised protocols for various lengths, variations, and starting concentrations.
- Preserving Oligonucleotide Integrity: For oligonucleotides, maintaining an RNase-free environment can be crucial. Selecting the optional inert gas blanket further safeguards integrity.
Genevac, in collaboration with Biopharma Group across the UK and Ireland, offers a comprehensive solution for your oligonucleotide needs.
- Expert Application Support: A team of specialists can collaborate with you to develop optimised protocols specifically for your oligonucleotide samples. A life-time service included with every new system.
- Streamlined Workflow: Genevac's intuitive interface and user-friendly design simplify the evaporation process, saving you valuable time and minimising errors.
- Unparalleled Reliability: Genevac evaporators are renowned for their robust construction and exceptional reliability, ensuring consistent results experiment after experiment.
For oligonucleotide research, the Genevac EZ-2 4.0 solvent evaporator emerges as the ideal choice. Its innovative features cater specifically to the needs of these molecules:
- Sample Protection Technology: This technology utilises an infrared sensor to monitor and control sample temperature in real-time, preventing overheating and safeguarding the integrity of your precious oligonucleotides, whilst providing automatic stop of run detection when your samples are dry, or the concentration end point is reached. Say “hello” to peace of mind for over-night runs and increased throughput!
- Genevac Cold Trap: This innovative cold trap efficiently captures a wide range of solvents, volatile organics, water, and high boiling point solvents without the need for long defrost times, minimizing solvent carryover and improving turnaround times.
- Compact Design, High Performance: The EZ-2's small footprint maximizes valuable bench space while delivering exceptional performance, perfect for busy research labs working with numerous oligonucleotide samples.
With Biopharma Group and Genevac, unlock the full potential of your oligonucleotide research. Our combined expertise and cutting-edge technology empower you to achieve optimal sample preparation, paving the way for groundbreaking discoveries.
Contact Biopharma Group* today for a personalised consultation and discover how Genevac can elevate your oligonucleotide research to new heights.
Other Press Releases By This Company
- 14/06/2024 - TECNIC appoints Biopharma Group as their new approved distributor for the UK & Ireland
- 28/03/2022 - The importance/challenges of mRNA vaccines, and how the correct lyo and fill/finish equipment can support your mRNA ambitions.
- 15/03/2022 - Advanced HPLC Provides Rapid Screening Method Development of Peptides and Oligonucleotides in Drug & Vaccine Discovery
- 18/02/2022 - BPS Crowthorne Moves Toward a Greener Future
- 01/07/2021 - A 2020 Hindsight Look at How COVID-19 Has Affected the Freeze Drying Industry and What We Have Learned from ItDr.
- 01/07/2021 - Why was utilising CRO services for freeze drying, so vital in response to Covid-19?
- 05/06/2020 - Vial Processing Advances Reducing Contamination and Damage
- 09/03/2020 - May 2020 - Biopharma Group Take the Avestin B15 on Tour in Ireland
- 09/03/2020 - Consumer demand drives the need for production scale freeze dried pet food
- 09/03/2020 - Biopharma Group joins forces with UCL & PMTC to expand lyo training course offerings.
- 15/01/2020 - Biopharma Group Adds Another Exciting Range to its Product Portfolio
- 20/11/2019 - High Pressure Homogenisation for the Cell Disruption of Algae
- 29/05/2018 - Why pre-formulation studies are crucial to successful drug development
- 29/05/2018 - The Avestin EmulsiFlex B15: The Improved French Press
- 20/12/2017 - ADCs and BIOSIMILARS: The development towards a new generation of targeted therapies
- 20/11/2017 - How the Adaptability of Liposomes Assists in Overcoming Today’s Drug Delivery Challenges
- 02/11/2017 - High Pressure Homogenisation: Binding Albumin Nanoparticles to Paclitaxel
- 19/09/2017 - How freeze drying optimises the processing and viability of collagen bio-scaffolds
- 13/09/2017 - When did your analytical instruments have a maintenance inspection?
- 17/08/2017 - The Rise of Low Maintenance, Automated Aseptic Processing Lines
- 08/08/2017 - Freeze Drying vs Spray Drying: is it essentially quality vs cost?
- 24/03/2017 - Why Lyophilisation Training Courses Are A Lab Essential
- 24/03/2017 - Refurbished Lyotherm2 For Sale
